{"id":"W4379281020","doi":"10.1200/jco.2023.41.16_suppl.8002","title":"First results from the RedirecTT-1 study with teclistamab (tec) + talquetamab (tal) simultaneously targeting BCMA and GPRC5D in patients (pts) with relapsed/refractory multiple myeloma (RRMM).","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Health Services; McGill University","funders":"Janssen Research and Development","keywords":"Medicine; Internal medicine; Neutropenia; Oncology; Multiple myeloma; Lenalidomide; Regimen; Alemtuzumab; Bortezomib; Chemotherapy; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003760318,0.0003272145,0.001579697,0.0002371165,0.0002091099,0.00003885514,0.0003060123,0.0003364499,0.00003182086],"category_scores_gemma":[0.02044264,0.000168985,0.0001803613,0.0005695823,0.0004127256,0.0001922788,0.0001747203,0.00189029,0.00003356828],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003082673,"about_ca_system_score_gemma":0.0007816147,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007355092,"about_ca_topic_score_gemma":0.005015454,"domain_scores_codex":[0.9943528,0.0009526147,0.00241784,0.0005753377,0.001114361,0.0005870154],"domain_scores_gemma":[0.9804106,0.01635865,0.001528181,0.0004685626,0.0006622809,0.0005716605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07728489,0.005409875,0.845004,0.00001940861,0.0007781324,0.009455337,0.001079188,0.0001335507,0.00001471435,6.534834e-7,0.001466416,0.05935382],"study_design_scores_gemma":[0.08060952,0.04272748,0.8620149,0.0002949636,0.0002447262,0.00007951787,0.001576531,0.001221705,0.000009510492,0.00001483535,0.0110415,0.0001648092],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948539,0.0001597011,0.000004793378,0.003010075,0.0002868897,0.001204022,0.0000649962,0.00004185793,0.0003737589],"genre_scores_gemma":[0.9972816,0.0003369054,0.00124247,0.0002772061,0.0004878254,0.00002361391,0.00005958938,0.00005264884,0.0002381789],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05918901,"threshold_uncertainty_score":0.9878086,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05943540418970244,"score_gpt":0.3796287968766242,"score_spread":0.3201933926869217,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}